RE: Nice ESG update on twitter5 Sep 2023 18:04
SJ - I don't disagree with much of your analysis and logic. IF the financing goes through, then there is clearly upside potential to be had in GCAT for sure, especially from these low levels. In answer to your question, had the OCIM funding gone through, and given a decent POG, most posters on here were confident of seeing an initial re-rate towards 3p - 4p. This was based solely on the Kilimapesa expansion to 24Koz. I don't know about now, as I've not given it any thought yet.
"The way we assess the risk-return trade-off determines if you see good value at the current price, or not. That is ultimately for everyone to do their research on and make their decision."
Again, I agree with this and have been saying as much in my recent posts. I don't wish to run the risk of the financing falling through again, or becoming 'delayed'. Another, albeit secondary issue, is also wanting to see the Prospectus. At present, the interim movements of the share price, haven't changed my risk analysis and overall pov. If anything, a declining and low share price can only fortify my decision to wait, for the reason that I have already explained. All imo and dyor